Atomistry » Fluorine » PDB 3nlz-3og7 » 3og7
Atomistry »
  Fluorine »
    PDB 3nlz-3og7 »
      3og7 »

Fluorine in PDB 3og7: B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032

Enzymatic activity of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032

All present enzymatic activity of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032:
2.7.11.1;

Protein crystallography data

The structure of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032, PDB code: 3og7 was solved by Y.Zhang, K.Y.Zhang, C.Zhang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 21.30 / 2.45
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 50.770, 104.424, 110.128, 90.00, 90.00, 90.00
R / Rfree (%) 21.3 / 25.8

Other elements in 3og7:

The structure of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 (pdb code 3og7). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032, PDB code: 3og7:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 3og7

Go back to Fluorine Binding Sites List in 3og7
Fluorine binding site 1 out of 2 in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1

b:33.0
occ:1.00
F25 A:0321 0.0 33.0 1.0
C24 A:0321 1.3 34.8 1.0
C23 A:0321 2.3 24.6 1.0
C18 A:0321 2.4 35.4 1.0
C17 A:0321 2.8 34.1 1.0
C16 A:0321 3.2 37.8 1.0
C15 A:0321 3.2 37.5 1.0
O19 A:0321 3.6 44.0 1.0
C22 A:0321 3.6 29.6 1.0
C20 A:0321 3.6 26.2 1.0
CB A:ALA481 3.6 44.4 1.0
CB A:LYS483 3.9 30.8 1.0
CG1 A:VAL471 3.9 52.8 1.0
OG1 A:THR529 4.0 36.0 1.0
N A:LYS483 4.0 36.1 1.0
C A:ALA481 4.0 39.3 1.0
O A:ALA481 4.0 36.7 1.0
C21 A:0321 4.1 27.3 1.0
CG2 A:VAL471 4.2 41.2 1.0
C A:VAL482 4.2 35.5 1.0
N A:VAL482 4.2 40.0 1.0
C05 A:0321 4.3 42.7 1.0
N14 A:0321 4.3 34.9 1.0
CA A:LYS483 4.3 31.2 1.0
CA A:ALA481 4.4 31.9 1.0
O A:ILE527 4.5 37.1 1.0
CB A:VAL471 4.6 47.2 1.0
CA A:VAL482 4.6 34.1 1.0
CG2 A:THR529 4.7 31.0 1.0
O A:VAL482 4.7 35.0 1.0
F26 A:0321 4.7 41.1 1.0
C06 A:0321 4.9 40.7 1.0
CG A:LYS483 4.9 33.6 1.0
CB A:THR529 4.9 31.8 1.0

Fluorine binding site 2 out of 2 in 3og7

Go back to Fluorine Binding Sites List in 3og7
Fluorine binding site 2 out of 2 in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1

b:41.1
occ:1.00
F26 A:0321 0.0 41.1 1.0
C20 A:0321 1.3 26.2 1.0
C18 A:0321 2.4 35.4 1.0
C21 A:0321 2.4 27.3 1.0
N27 A:0321 2.7 36.6 1.0
C17 A:0321 2.8 34.1 1.0
O19 A:0321 3.0 44.0 1.0
N A:ASP594 3.5 49.2 1.0
O A:HOH44 3.5 50.8 1.0
CE1 A:PHE583 3.6 54.1 1.0
C24 A:0321 3.6 34.8 1.0
C22 A:0321 3.6 29.6 1.0
CD2 A:LEU514 3.6 35.3 1.0
CZ A:PHE583 3.7 55.4 1.0
C16 A:0321 3.8 37.8 1.0
C A:GLY593 3.9 63.3 1.0
CA A:GLY593 4.0 59.8 1.0
CA A:ASP594 4.1 34.5 1.0
CB A:ASP594 4.1 53.7 1.0
C23 A:0321 4.1 24.6 1.0
C15 A:0321 4.4 37.5 1.0
S28 A:0321 4.4 52.0 1.0
F25 A:0321 4.7 33.0 1.0
O A:GLY593 4.7 69.0 1.0
CD1 A:PHE583 4.8 63.9 1.0
CG A:ASP594 4.8 76.6 1.0
NZ A:LYS483 4.8 32.4 1.0
C05 A:0321 4.9 42.7 1.0
CE2 A:PHE583 4.9 66.8 1.0
CE A:LYS483 5.0 32.7 1.0

Reference:

G.Bollag, P.Hirth, J.Tsai, J.Zhang, P.N.Ibrahim, H.Cho, W.Spevak, C.Zhang, Y.Zhang, G.Habets, E.A.Burton, B.Wong, G.Tsang, B.L.West, B.Powell, R.Shellooe, A.Marimuthu, H.Nguyen, K.Y.Zhang, D.R.Artis, J.Schlessinger, F.Su, B.Higgins, R.Iyer, K.D'andrea, A.Koehler, M.Stumm, P.S.Lin, R.J.Lee, J.Grippo, I.Puzanov, K.B.Kim, A.Ribas, G.A.Mcarthur, J.A.Sosman, P.B.Chapman, K.T.Flaherty, X.Xu, K.L.Nathanson, K.Nolop. Clinical Efficacy of A Raf Inhibitor Needs Broad Target Blockade in Braf-Mutant Melanoma. Nature V. 467 596 2010.
ISSN: ISSN 0028-0836
PubMed: 20823850
DOI: 10.1038/NATURE09454
Page generated: Sun Dec 13 11:52:14 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy